This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, G. A. Articles by Kyner, W. T. Search for Related Content PubMed PubMed Citation Articles by Rosenberg, G. A. Articles by Kyner, W. T.

Stroke, Vol 23, 1767-1773, Copyright © 1992 by American Heart Association

ARTICLES

Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats [published erratum appears in Stroke 1993 Jun;24(6):913]

GA Rosenberg, O Scremin, E Estrada and WT Kyner
Neurology Service, Veterans Affairs Medical Center, Albuquerque, N.M.

BACKGROUND AND PURPOSE: Injection of arginine vasopressin into the cerebral ventricles in animals with brain injury increased brain water, whereas injection of atrial natriuretic peptide reduced water content. Therefore, to determine the role of endogenous arginine vasopressin in brain edema, we attempted to inhibit edema from a hemorrhagic lesion with an arginine vasopressin V1 receptor antagonist or atrial natriuretic peptide. METHODS: Adult Sprague-Dawley rats with hemorrhages induced by 0.4 IU bacterial collagenase were treated with 75 ng (n = 9) or 8 micrograms (n = 9) of the vasopressin V1 receptor antagonist d(CH2)5Tyr(Me)Arg, 3.2 micrograms (n = 4) atrial natriuretic peptide injected intracerebrally, or 5 micrograms/kg per hour (n = 7) atrial natriuretic peptide intraperitoneally. They were compared with control groups injected with 0.4 IU collagenase only. Brain water and electrolytes were measured 24 hours later. Brain uptake of [14C]sucrose was measured 30 minutes after lesions were induced by 0.4 IU collagenase alone (n = 5) or after collagenase injection and 50 micrograms/kg per hour (n = 5) atrial natriuretic peptide injected intravenously. RESULTS: The arginine vasopressin V1 receptor antagonist and atrial natriuretic peptide significantly (p < 0.05) reduced water and sodium contents in the posterior edematous regions. Brain uptake of [14C]sucrose was significantly reduced by intravenous atrial natriuretic peptide. CONCLUSIONS: Antagonists to arginine vasopressin V1 receptors and atrial natriuretic peptide both significantly reduce hemorrhagic brain edema, and atrial natriuretic peptide appears to protect the blood-brain barrier.

This article has been cited by other articles:

				M. Altumbabic, J. Peeling, M. R. Del Bigio, and R. L. Macdonald Intracerebral Hemorrhage in the Rat: Effects of Hematoma Aspiration • Editorial Comment Stroke, September 1, 1998; 29(9): 1917 - 1923. [Abstract] [Full Text] [PDF]

				C. G. a. C. Oberlander The Kappa Opioid Agonist Niravoline Decreases Brain Edema in the Mouse Middle Cerebral Artery Occlusion Model of Stroke J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 1 - 6. [Abstract] [Full Text]

				M. R. D. Bigio, H.-J. Yan, R. Buist, J. Peeling, and G. J. del Zoppo Experimental Intracerebral Hemorrhage in Rats: Magnetic Resonance Imaging and Histopathological Correlates Stroke, December 1, 1996; 27(12): 2312 - 2320. [Abstract] [Full Text]

				G. A. Rosenberg and E. Y. Estrada Atrial Natriuretic Peptide Blocks Hemorrhagic Brain Edema After 4-Hour Delay in Rats Stroke, May 1, 1995; 26(5): 874 - 877. [Abstract] [Full Text]

				E. Kozniewska, T. P. L. Roberts, Z. S. Vexler, M. Oseka, J. Kucharczyk, and A. I. Arieff Hormonal Dependence of the Effects of Metabolic Encephalopathy on Cerebral Perfusion and Oxygen Utilization in the Rat Circ. Res., April 1, 1995; 76(4): 551 - 558. [Abstract] [Full Text]